Buxton, United Kingdom

Craig Wilson

USPTO Granted Patents = 2 

Average Co-Inventor Count = 27.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
2 patents (USPTO):

Title: The Innovative Journey of Inventor Craig Wilson

Introduction

Craig Wilson, an accomplished inventor based in Buxton, GB, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Wilson's work primarily focuses on macrocyclic indole derivatives, demonstrating his expertise in developing novel compounds for therapeutic applications.

Latest Patents

Wilson's recent innovations include two patents for macrocyclic chlorine substituted indole derivatives. These inventions relate to compounds defined by a general formula, detailing methods for their preparation and the use of these compounds in pharmaceutical compositions. Specifically, they target the treatment or prophylaxis of hyperproliferative disorders, either as standalone agents or in combination with other active ingredients. His research underscores the potential of these derivatives in advancing medical science and treatment methodologies.

Career Highlights

Throughout his career, Craig Wilson has worked with notable organizations such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure at these companies has enriched his experience and provided a platform for translating his innovative ideas into tangible pharmaceutical solutions.

Collaborations

Collaboration has been a key aspect of Wilson's journey. He has worked alongside talented coworkers like Kai Thede and Anne Mengel. These partnerships have enhanced the quality of his research and contributed to successful projects, further solidifying his reputation in the pharmaceutical industry.

Conclusion

In summary, Craig Wilson stands out as a notable inventor whose work on macrocyclic indole derivatives has the potential to make significant impacts in the medical field. His collaborations and career at major pharmaceutical companies have equipped him with the skills and insights necessary to innovate effectively. As he continues to push the boundaries of pharmaceutical research, the industry watches with anticipation for what he will achieve next.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…